ZRANB1 Antikörper (C-Term)
Kurzübersicht für ZRANB1 Antikörper (C-Term) (ABIN929204)
Target
Alle ZRANB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- ZRANB1 antibody was raised in rabbit using the C terminal of ZRANB1 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ZRANB1 (Zinc Finger, RAN-Binding Domain Containing 1 (ZRANB1))
-
Andere Bezeichnung
- ZRANB1
-
Hintergrund
- ZRANB1 is a positive regulator of the Wnt signaling pathway that specifically cleaves 'Lys-63'-linked ubiquitin chains.ZRANB1 acts by deubiquitinating APC protein, a negative regulator of Wnt-mediated transcription. ZRANB1 may also modulate TNF-alpha signaling. Synonyms: Polyclonal ZRANB1 antibody, Anti-ZRANB1 antibody, zinc finger, RAN-binding domain containing 1 antibody, DKFZp762P2216 antibody, TRABID antibody.
Target
-